Angioplasty and stenting (A/S) provide an alternative for patients with simultaneous severe cardiac and cerebrovascular disease, or with medical illnesses which carry a high perioperative risk. We conducted A/S in 20 high-risk patients (15 males, 5 females, mean age = 64.5 years, range = 49–83 years) with symptomatic (n = 16) and asymptomatic (n = 4) high-grade stenosis (>70%, NASCET criterion) of the internal carotid artery. Patients had neurological examinations before, during and after the procedure. Color-coded duplex sonography was performed before and 24 h and every 3 months after the procedure; the 3-month examination also included cerebral angiography. The mean degree of stenosis was reduced from 85.75 ± 7.47 to 8.0 ± 22.09% in angiography. In an 18-month follow-up with color-coded duplex sonography the effects of the A/S could be visualized effectively: 2 with local, transient vasospasms, 1 with asymptomatic occlusion, 2 carotid arteries with remaining stenosis of 50% and 2 with minimal hyperplasia within the stent. In conclusion, in patients with a high perioperative risk, A/S is a therapeutic alternative to surgery.

Keywords:
Stent, Carotid artery, Carotid endarterectomy, Ultrasound
1.
Marks MP, Dake MD, Steinberg GK, Norbash AM, Lane B: Stent placement for arterial and venous cerebrovascular disease: Preliminary experience. Radiology 1994;191:441–446.
2.
Yadav JS, Roubin GS, King P, Iyer S, Vitek J: Angioplasty and stenting for restenosis after carotid endarterectomy. Stroke 1996;27:2075–2079.
3.
Yadav JS, Roubin GS, Iyer S, Vitek J, King P, Jordan WD, Fisher WS: Elective stenting of the extracranial carotid arteries. Circulation 1997;95:376–381.
4.
deBray JM, Glatt B: Quantification of atheromatous stenosis in the extracranial internal carotid artery. Cerebrovasc Dis 1995;5:414–426.
5.
Alexandrov AV, Bladin CF, Maggisano R, Norris JW: Measuring carotid stenosis: Time for a reappraisal. Stroke 1993;24:1292–1296.
6.
von Reutern GM, von Büdingen HJ: Ultrasound Diagnosis of Cerebrovascular Disease. Stuttgart, Thieme, 1993.
7.
North American Symptomatic Carotid Endarterectomy Trial Collaborators: Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med 1991;325:445–452.
8.
Griewing B, Brassel F, Schminke U, Kessler Ch: Angioplasty and stenting in carotid artery dissection. Eur Neurol 1998;40:175–176.
9.
European Carotid Surgery Trialists’ Group: MRC European Carotid Surgery Trial: Interim results for symptomatic patients with severe (70–99%) or with mild (0–29%) carotid stenosis. Lancet 1991,337:1235–1243.
10.
Executive Committee for the Asymptomatic Carotid Atherosclerosis Study: Endarterectomy for asymptomatic carotid artery stenosis. JAMA 1995;273:1421–1428.
11.
Sundt TM Jr, Meyer FB, Piepgras DG, Fodee NC, Ebersold NJ, Marsh WR: Risk factors and operative results; in Meyer FB (ed): Sundt’s Occlusive Cerebrovascular Disease, ed 2. Philadelphia, Saunders Co, 1994, pp 241–247.
12.
Higashida RT, Tsai FY, Halbach V, Dowd C, Smith T, Fraser K, Hieshima G: Transluminal angioplasty for atherosclerotic disease of the vertebral and basilar arteries. J Neurosurg 1993;78:192–198.
13.
Tobis JM: Clinical significance of an abnormal coronary flow reserve. Cathet Cardiovasc Diagn 1995;36:281–232.
© 2000 S. Karger AG, Basel
2000
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.